Genetic polymorphism of apolipoprotein A5 gene and susceptibility to type 2 diabetes mellitus: A meta-analysis of 15,137 subjects

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Yin, Yan Wei ^a   Sun, Qian Qian ^b   Wang, Pei Jian ^c   Qiao, Li ^a   Hu, Ai Min ^a   Liu, Hong Li ^a   Wang, Qi ^a   Hou, Zhi Zhen ^a  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b Jinsong Sanatorium of Beijing Air Force   (China)

^c FIRST AFFILIATED HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A;

ALLELE; APOA5 GENE; ARTICLE; ASIAN; CAUCASIAN; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION GENETICS; RISK ASSESSMENT; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; ETHNOLOGY; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA;

APOLIPOPROTEINS A; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84896769536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089167     Document Type: Article

References (45)

1. Gulliford MC, Charlton J (2009) Is relative mortality of type 2 diabetes mellitus decreasing?. Am J Epidemiol 169: 455-461.
2. International Diabetes Federation (2012) Available at: http://www.diabetesatlas.org/content/diabetes. Accessed: Feb 10, 2012.
3. Lin JD, Hsia TL, Wu CZ, Su CC, Ma WY, et al. (2010) The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus. Metabolism 59: 780-786.
4. Li XF (2002) Study on the association of apolipoprotein A5 gene single nucleotide polymorphisms with type II diabetes. Fujian Medical University (Master thesis) 1-51.
5. Chaaba R, Attia N, Hammami S, Smaoui M, Mahjoub S, et al. (2005) Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes. Lipids Health Dis 4: 1-6.
6. Yan SK, Cheng XQ, Song YH, Xiao XH, Bi N, et al. (2005) Apolipoprotein A5 gene polymorphism -1131T-.C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese. Clin Chem Lab Med 43: 607-612. (Pubitemid 41460610)
7. Liu HK (2005) Study on the association of single nucleotide polymorphisms in apolipoprotein APOA I/C3/A4/A5 gene cluster with coronary heart disease and type II diabetes. Sichuan University (Doctor thesis) 1-108.
8. Talmud PJ, Cooper JA, Hattori H, Miller IP, Miller GJ, et al. (2006) The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia 49: 2337-2340. (Pubitemid 44359094)
9. Baum L, Ng MC, So WY, Poon E, Wang Y, et al. (2007) A case-control study of apoA5 -1131T->C polymorphism that examines the role of triglyceride levels in diabetic nephropathy. J Diabetes Complications 21: 158-163. (Pubitemid 46687067)
10. Cheng XQ, Yan SK, Song YH, Xiao XH, Bi N, et al. (2007) Relationship between Apolipoprotein AV gene-1131T>C polymorphism and Type 2 Diabetes Mellitus with Coronary Heart Disease in Han Nationality. Molecular Cardiology of China 7: 189-194.
11. Zhai GH, Wen P, Guo LF, Chen L (2007) Association of apolipoprotein A5 gene -1131T/C polymorphism with lipid metabolism and insulin resistance in patients with type II diabetes mellitus. HEREDITAS (Beijing) 541-546.
12. Zhou YL, Fu P, Fu XY, Ding Y, Zhu MA (2008) Study on the relationship between apolipoprotein A5 gene polymorphism and type 2 diabetic mellitus retinopathy. Journal of Chinese Practical Diagnosis and Therapy 22: 815-817.
13. Feng CS (2009) The Relationships of CYP11B2, ApoA5 Gene Polymorphisms and Type 2 Diabetes with Nephropathy. Qingdao University (Master thesis) 1-44.
14. Qiao Y, Liu R, Tian HM, Liu Y, Qiang O, et al. (2008) Association of Apolipoprotein A5 Gene-1131T/C Polymorphism with Serum Lipids and Carotid Intima-media Thickness in Patients with Type 2 Diabetes Mellitus. Journal of Sichuan University(Medical Science Edition) 39: 965-968.
15. Li X, Xu Y, Ding Y, Qin C, Dai Z, et al. (2008) Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes. J Huazhong Univ Sci Technolog Med Sci 28: 653-656.
16. Zhang S (2009) Relationship between Apolipoprotein AV Gene-1131T/C Polymorphism and Type 2 Diabetes Mellitus in Han Nationality. Zhongshan University (Master thesis) 1-37.
17. Li HX, Zhao ZP, Zhao YG, Wen LY, Zhang Z (2009) Study on the Relationship of Apolipoprotein A5 Gene-1131T/C Polymorphism with lipid protein(a) and homocysteinemia levels in patients with diabetic nephropathy. China Practical Medicine 4: 40-42.
18. Xiao H, Zhang MY, Li HQ, Zheng YJ, Liu S, et al. (2010) Study on the association of APOA5 -1131T/C gene polymorphism with 2 diabetes in uygurs. Modern Preventive Medicine 37: 722-732.
19. Bhaskar S, Ganesan M, Chandak GR, Mani R, Idris MM, et al. (2011) Association of PON1 and APOA5 gene polymorphisms in a cohort of Indian patients having coronary artery disease with and without type 2 diabetes. Genet Test Mol Biomarkers 15: 507-512.
20. Sóter MO, Gomes KB, Fernandes AP, Carvalho Md, Pinheiro PS, et al. (2012) - 1131T.C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients. Mol Biol Rep 39:7541-7548.
21. Yao WM, Zhang HF, Zhu ZY, Zhou YL, Liang NX, et al. (2013) Genetically elevated levels of circulating triglycerides and brachial-ankle pulse wave velocity in a Chinese population. J Hum Hypertens 27:265-270.
22. Can Demirdöǧen B, Şahin E, Türkanoǧlu Özçelik A, Bek S, et al. (2012) Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke. Mol Biol Rep 39: 10459-10468.
23. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173. (Pubitemid 32952971)
24. van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, et al. (2001) Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276: 44512-44520.
25. Aouizerat BE, Kulkarni M, Heilbron D, Drown D, Raskin S, et al. (2003) Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 44: 1167-1173. (Pubitemid 37279634)
26. Austin MA, Talmud PJ, Farin FM, Nickerson DA, Edwards KL, et al. (2004) Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans. Biochim Biophys Acta 1688: 1-9. (Pubitemid 38366300)
27. Martin S, Nicaud V, Humphries SE, Talmud PJ; EARS group (2003) Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 1637: 217-225.
28. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, et al. (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11: 3031-3038. (Pubitemid 35414816)
29. Maász A, Kisfali P, Horvatovich K, Mohás M, Markó L, et al. (2007) Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. Pathol Oncol Res 13: 243-247. (Pubitemid 350221227)
30. Li J, Xu H, Zhu X (2007) Association of APOA5 gene polymorphism with levels of lipids and atherosclerotic cerebral infarction in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (Chinese) 24: 576-578. (Pubitemid 47597758)
31. Barbosa FA, de Labio RW, de Oliveira S Rigolin V, Minett T, Bertolucci PH, et al. (2006) Apolipoprotein A-V gene polymorphism -1131T >C and Alzheimer's disease. J Alzheimers Dis 10:365-369.
32. Xu C, Bai R, Zhang D, Li Z, Zhu H, et al. (2013) Effects of APOA5 -1131T.C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis. PLoS One 8:e56216.
33. Liu CF, Yang QF, Chen XL, Liu CY (2012) Apolipoprotein a5 gene polymorphism and risk for metabolic syndrome: a meta-analysis. Genet Test Mol Biomarkers 16:1241-1245.
34. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151: 264-269.
35. Wells GA, Shea B, O'Connell D (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute. www.ohri.ca/programs/clinical-epidemiology/oxford.asp (accessed Oct 20, 2011).
36. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
37. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA (1995) A random-effects regression model for meta-analysis. Stat Med 14: 395-411.
38. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
39. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
40. Yin YW, Sun QQ, Zhang BB, Hu AM, Liu HL, et al. (2013) Association between Apolipoprotein E Gene Polymorphism and the Risk of Coronary Artery Disease in Chinese Population: Evidence from a Meta-Analysis of 40 Studies. PLoS One 2013;8(6):e66924.
41. Yin YW, Hu AM, Sun QQ, Zhang BB, Liu HL, et al. (2013) Association between interleukin 10 gene -1082 A/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis of 4250 subjects. Cytokine 62: 226-231.
42. Tang L, Wang L, Liao Q, Wang Q, Xu L, et al. (2013) Genetic associations with diabetes: meta-analyses of 10 candidate polymorphisms. PLoS One 8: e70301.
43. International HapMap Project (2013) Available at: http://hapmap.ncbi.nlm. nih.gov. Accessed: October 29, 2013.
44. Wang W, Liu J, Sun JY, Wang M, Liu J, et al. (2012) The association between the changes in triglyceride levels and the risk of incident type 2diabetes mellitus: a 15 years followed-up results from the Chinese Multi-provincial Cohort Study. Zhonghua Nei Ke Za Zhi 51: 516-519.
45. Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Heterogeneity in meta-analyses of genome-wide association investigations. PLoS One 2: e841.